Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-24 @ 5:58 AM
Study NCT ID:
NCT00663832
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2008-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer
Sponsor:
Novartis Pharmaceuticals
Organization: